Leukocytes and the inflammatory response in ischemia-reperfusion injury;Os leucócitos e a resposta inflamatória na lesão de isquemia-reperfusão

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 4, 2010, Pages 575-584

  Francischetti, Ieda ^a   Moreno, José Bitu ^a   Scholz, Martin ^b   Yoshida, Winston Bonetti ^c  

^a Medicine Faculty of Marilia   (Brazil)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cardiopulmonary bypass; Ischemia; Leukocytes; Reperfusion injury

Indexed keywords

APOPTOSIS; ARTICLE; CELL ADHESION; EXTRACORPOREAL CIRCULATION; HUMAN; IMMUNOLOGY; LEUKOCYTE; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

APOPTOSIS; CELL ADHESION; EXTRACORPOREAL CIRCULATION; HUMANS; LEUKOCYTES; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79952260687     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S0102-76382010000400023     Document Type: Article

References (68)

1. World Health Organization. Programmes and Projects: Cardiovascular disease [site na Internet]. Ginebra: WHO; 2009. [cited 2009 Apr 17]. Disponível em: http://www.who.int/cardiovascular_diseases/en/
2. Ministério da Saúde (BR). DATASUS. Indicadores de mortalidade: taxa de mortalidade específica por doenças do aparelho circulatório [site na Internet]. Brasília: DATASUS; 2009. [citado 2009 abr 17]. Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2007/c08.def
3. Silveira M, Yoshida WB. Isquemia e reperfusão em músculo esquelético: mecanismo de lesão e perspectivas de tratamento. J Vasc Br. 2004;3(4):367-78.
4. Moura HV, Pomerantzeff PMA, Gomes WJ. Síndrome da resposta inflamatória sistêmica na circulação extracorpórea: papel das interleucinas. Rev Bras Cir Cardiovasc. 2001;16(4):376-87.
5. Yoshida WB. Radicais livres na síndrome da isquemia e reperfusão. Cir Vasc Angiol. 1996;12:82-95.
6. Mitchell RN, Kumar V, Abbas AK, Fausto N. Inflamação aguda e crônica. In: Robbins & Cotran: fundamentos de patologia. 7a ed. Rio de Janeiro: Elsevier; 2006. p.29-54.
7. Clark SC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21(4):225-8.
8. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988;255(6 Pt 2):H1269-75.
9. Grace PA. Ischemia-reperfusion injury. Br J Surg. 1994;81(5):637-47.
10. Del Maestro RF, Planker M, Arfors KE. Evidence for the participation of superoxide anion radical in altering the adhesive interaction between granulocytes and endothelium, in vivo. Int J Microcirc Clin Exp. 1982;1(2):105-20.
11. Johnson D, Thomson D, Hurst T, Prasad K, Wilson T, Murphy F, et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg. 1994;107(5):1193-202.
12. Kirschner RE, Fantini GA. Role of iron and oxygen-derived free radicals in ischemia-reperfusion injury. J Am Coll Surg. 1994;179(1):103-17.
13. Junqueira LC, Carneiro C. Histologia básica. 10a ed. Rio de Janeiro:Guanabara Koogan;2004. p.223-37.
14. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest. 1993;91(2):379-87.
15. Stewart M, Thiel M, Hogg N. Leukocyte integrins. Curr Opin Cell Biol. 1995;7(5):690-6.
16. Lu H, Ballantyne C, Smith CW. LFA-1 (CD11a/CD18) triggers hydrogen peroxide production by canine neutrophils. J Leukoc Biol. 2000;68(1):73-80.
17. Gourlay T, Asimakopoulos G, Taylor KM. Leukocyte biology and pathogenicity in cardiac surgery and cardiology: the need for leukocyte depletion. In: Matheis G, Moritz A, Scholz M, eds. Leukocyte depletion in cardiac surgery and cardiology. Basel:Karger;2002. p.1-12.
18. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg. 2001;71(2):745-54.
19. Cerqueira NF, Yoshida WB. Óxido nítrico. Revisão. Acta Cir Bras. 2002;17(6):417-42.
20. Gianetti J, Del Sarto P, Bevilacqua S, Vassalle C, De Filippis R, Kacila M, et al. Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg. 2004;127(1):44-50.
21. Carvalho MHC, Nigro D, Lemos VS, Tostes RCA, Fortes ZB. Hipertensão arterial: o endotélio e suas múltiplas funções. Rev Bras Hipertens. 2001;8(1):76-88.
22. Fernandez-Patron C, Zouki C, Whittal R, Chan JS, Davidge ST, Filep JG. Matrix metalloproteinases regulate neutrophil- endothelial cell adhesion through generation of endothelin-1[1- 32]. FASEB. 2001;15(12):2230-40.
23. Gulbins E, Jekle A, Ferlinz K, Grassmé H, Lang F. Physiology of apoptosis. Am J Physiol Renal Physiol. 2000;279(4):F605-15.
24. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239-57.
25. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745-56.
26. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol. 2002;192(1):1-15.
27. Mitchell RN, Kumar V, Abbas AK, Fausto N. Adaptações celulares, lesão celular e morte celular. In: Robbins & Cotran: fundamentos de patologia. 7a ed. Rio de Janeiro: Elsevier;2006. p.3-28.
28. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 1998;97(3):276-81.
29. Stephenson LH. History of cardiac surgery. In: Cohn LH, Edmunds LH Jr., eds. Cardiac surgery in the adult. New York:McGraw-Hill;2003. p.329.
30. Gomes WJ, Saba JC, Buffolo E. 50 anos de circulação extracorpórea no Brasil: Hugo J. Felipozzi, o pioneiro da circulação extracorpórea no Brasil. Rev Bras Cir Cardiovasc. 2005;20(4):3-8.
31. Brasil LA, Gomes WJ, Salomão R, Buffolo E. Ativação de citocina (fator de necrose tumoral - alfa) e resposta clínica induzida pela circulação extracorpórea. Rev Bras Cir Cardiovasc. 1996;11(3):188-200.
32. Sievers HH, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe H, Kraatz EG, et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg. 2002;74(4):1167-72.
33. Wang QP, Gu JW, Zhan XH, Li H, Luo XH. Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem. 2009;46(Pt 6):495-500.
34. Gomes WJ, Erlichman MR, Batista-Filho ML, Knobel M, Almeida DR, Carvalho AC, et al. Vasoplegic syndrome after off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg. 2003;23(2):165-9.
35. Buffolo E, Branco JN, Gerola LR, Aguiar LF, Teles CA, Palma JH, et al. Off-pump myocardial revascularization: critical analysis of 23 years? experience in 3,866 patients. Ann Thorac Surg. 2006;81(1):85-9.
36. Brasil LA, Gomes WJ, Salomão R, Buffolo E. Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass. Ann Thorac Surg. 1998;66(1):56-9.
37. Lobo Filho JG, Leitão MCA, Lobo Filho HG, Soares JPH, Magalhães GA, Leão Filho CSC, et al. Cirurgia de revascularização coronariana esquerda sem CEC e sem manuseio da aorta em pacientes acima de 75 anos. Rev Bras Cir Cardiovasc. 2002;17(3):208-14.
38. Selke FW, DiMaio JM, Caplan LR, Ferguson TB, Gardner TJ, Hiratzka LF, et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation. 2005;111(21):2858-64.
39. Belkin M, LaMorte WL, Wright JG, Hobson RW 2nd. The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg. 1989;10(1):14-8.
40. el Habbal MH, Carter H, Smith LJ, Elliott MJ, Strobel S. Neutrophil activation in paediatric extracorporeal circuits: effect of circulation and temperature variation. Cardiovasc Res. 1995;29(1):102-7.
41. Dussin LH, Moura L, Gib MC, Saadi EK, Barbosa GV, Wender OCB. Análise ultra-estrutural do miocárdio usando solução cardioplégica cristalóide com e sem procaína em pacientes submetidos à troca valvar aórtica. Rev Bras Cir Cardiovasc. 2008;23(3):389-5.
42. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al; CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364(9442):1321-8.
43. Havlicek K, Motycka V, Siller J, Cervinka V. Systemic inflammatory response syndrome (SIRS) in serious chest injuries: is a pharmacological blockade effective? Ann Thorac Cardiovasc Surg. 2005;11(4):232-7.
44. Goebel U, Siepe M, Mecklenburg A, Doenst T, Beyersdorf F, Loop T, et al. Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation. Eur J Cardiothorac Surg. 2008;34(6):1165-72.
45. Bartels C, Gerdes A, Babin-Ebell J, Beyersdorf F, Boeken U, Doenst T, et al. Cardiopulmonary bypass: Evidence or experience based? J Cardiovasc Surg. 2002;124(1):20-7.
46. Greenwalt TJ, Gajewski M, McKenna JL. A new method for preparing buffy coat-poor blood. Transfusion. 1962;2:221-9.
47. Roth M, Kraus B, Scheffold T, Reuthebuch O, Klövekorn WP, Bauer EP. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg. 2000;120(4):642-50.
48. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocytes depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97(6):562-8.
49. Lick SD, Brown PS Jr, Kurusz M, Vertrees RA, McQuitty CK, Johnston WE. Technique of controlled reperfusion of the transplanted lung in humans. Ann Thorac Surg. 2000;69(3):910-2.
50. Alexiou C, Tang AA, Sheppard SV, Smith DC, Gibbs R, Livesey SA, et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study. Eur J Cardiothorac Surg. 2004;26(2):294-300.
51. Olivencia-Yurvati AH, Ferrara CA, Tierney N, Wallace N, Mallet RT. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post- cardiopulmonary bypass. Perfusion. 2003;18(Suppl 1):23-31.
52. Kiliç D, Gunaydin S, Kisa U, Sari T, Deveci O, Zorlutuna Y. Clinical efficacy of leukofiltration on cardiopulmonary bypass related inflammatory response: Fact or Foe? Inflamm Res. 2009;58(6):292-7.
53. Leal-Noval SR, Amaya R, Herruzo A, Hernández A, Ordóñez A, Marín-Niebla A, et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg. 2005;80(4):1394-400.
54. Baksaas ST, Flom-Halvorsen HI, Ovrum E, Videm V, Mollnes TE, Brosstad F., et al. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery. Perfusion. 1999;14(2):107-17.
55. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus Sci. 1999;20(3):151-65.
56. Scholz M, Simon A, Matheis G, Dzemali O, Henrich D, Kleine P, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002;51(7):363-8.
57. Ilmakunnas M, Pesonen EJ, Ahonen J, Rämö J, Siitonen S, Repo H. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass. J Thoracic Cardiovasc Surg. 2005;129(4):851-9.
58. Warren O, Alexiou C, Massey R, Leff D, Purkayastha S, Kinross J, et al. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg. 2007;31(4):665-76.
59. Los M, Burek CJ, Stroh C, Benedyk K, Hug H, Mackiewicz A. Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design. Drug Discov Today. 2003;8(2):67-77.
60. Everett H, McFadden G. Apoptosis: an innate immune response to virus infection. Trends Microbiol. 1999;7(4):160-5.
61. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, Assi LK., et al. Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood. 2004;104(8):2557-64.
62. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8(8):504-12.
63. Scholz M, Simon A, Berg M, Schuller AM, Hacibayramoglu M, Margraf S., et al. In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg. 2004;127(6):1735-42.
64. Lögters TT, Altrichter J, Paunel-Görgülü A, Sager M, Witte I, Ott A, et al. Extracorporeal immune therapy with immobilized agonistic anti-Fas antibodies leads to transient reduction of circulating neutrophil numbers and limits tissue damage after hemmorrhagic shock/resuscitation in a porcine model. J Inflamm (Lond). 2010;7:18.
65. Moreno JB, Margraf S, Schuller AM, Simon A, Moritz A, Scholz M. Inhibition of neutrophil activity in cardiac surgery with cardiopulmonary bypass: a novel strategy with the leukocyte inhibition module. Perfusion. 2004;19(1):11-6.
66. Greenstein S, Barnard J, Zhou K, Fong M, Hendey B. Fas activation reduces neutrophil adhesion to endothelial cells. J Leukoc Biol. 2000;68(5):715-22.
67. Curtin JF, Cotter TG. Live an let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal. 2003;15(11):983-92.
68. Abdel-Rahman U, Margraf S, Aybek T, Lögters T, Bitu- Moreno J, Francischetti I, et al. Inhibition of neutrophil activity improves cardiac function after cardiopulmonary bypass. J Inflamm (Lond). 2007;4:21.